Iyer, Srividya
Mustafa, Sally
Gariépy, Geneviève
Shah, Jai
Joober, Ridha
Lepage, Martin
Malla, Ashok
Funding for this research was provided by:
National Institute of Mental Health (MH093303)
Canadian Institutes of Health Research
CIHR New Investigator Award
Fonds de Recherche du Québec - Santé (FRQS) Clinician-Scientist Award
CIHR Post-Doctoral Award
FRQS Research Chair award
the Canada Research Chairs Program
Article History
Received: 11 April 2018
Accepted: 24 July 2018
First Online: 9 August 2018
Compliance with ethical standards
:
: Dr. Lepage reports grants from Otsuka Lundbeck Alliance and Janssen, and personal fees from Otsuka Canada, Lundbeck Canada, Janssen, MedAvante-Prophase and Amplexor, all of which are unrelated to the present article. Dr. Joober reports to be a speaker and/or consulting committee member for Pfizer, Janssen, BMS, Sunovian, Myelin, Otsuka, Lundbeck, Shire and Perdue, and to have received grants from Janssen, BMS, Otsuka, Lundbeck, Astra Zeneca and HLS, and to have royalties from Henry Stewart talks, all of which are unrelated to the present article. Dr. Malla reports research funding for an investigator-initiated project, unrelated to the present article, from BMS Canada and honoraria for lectures and consulting activities with Otsuka and Lundbeck, all of which are unrelated to the present article. Authors Iyer, Mustafa, Gariepy and Shah have nothing to declare.